InMode Ltd.
InMode Ltd. designs, develops, manufactures, and markets minimally invasive aesthetic medical products based on its proprietary radiofrequency assisted lipolysis and deep subdermal fractional radiofrequency technologies in the United States and internati…
Medical - Devices
IL, Yokne'am [HQ]
FA
Fundamental Analysis · Most Recent Quarter
A dedicated fundamental analysis might help you to get a quick overview
of the
financial stability. It is important to understand the
FA Algorithm
and the criterias before valuing it as a top-tier resource.
1
Financial Health
Metric | Q4 | Q1 | Δ in % | |
---|---|---|---|---|
Current Ratio | 2.05 | 13.45 | 13.18 | |
Debt/Assets | n.A. | n.A. | n.A. | |
Debt/Equity | n.A. | n.A. | n.A. | |
Net Debt/EBITDA | -138.38 | -6.28 | -2.64 | |
Naive Interpretation | member |
2
Per Share
Metric | Q4 | Q1 | Δ in % | |
---|---|---|---|---|
Book Value | 2.75 | 9.65 | 9.39 | |
Cash | 3.09 | 9.12 | 8.84 | |
Capex | -429.16 | < 0.005 | < 0.005 | |
Free Cash Flow | -61.12 | 0.28 | 0.73 | |
Revenue | -37.17 | 0.95 | 1.51 | |
Naive Interpretation | member |
3
Profitability
Metric | Q4 | Q1 | Δ in % | |
---|---|---|---|---|
Gross Margin | -5.24 | 0.80 | 0.84 | |
Operating Margin | -44.25 | 0.23 | 0.40 | |
ROA | -58.42 | 0.03 | 0.06 | |
ROE | -58.52 | 0.03 | 0.07 | |
ROIC | -66.09 | 0.02 | 0.06 | |
Naive Interpretation | member |
4
Valuation
The "Valuation Entry" for the Focus of INMD is permitted for members.
5
Growth
The "Growth Entry" for the Focus of INMD is permitted for members.
6
Leverage & Liquidity